ECMO(体外式薄膜型人工肺)的全球市场 2023-2027

ECMO(体外式薄膜型人工肺)的市场规模在2022年～2027年间，预测将成长到2亿4360万美元，在预测期间内预计将以以年复合成长率10.05％增长。

本报告提供ECMO(体外式薄膜型人工肺)市场整体分析，提供市场规模与预测，趋势，成长促进因素·课题，网罗了约25供应商的供应商分析等资讯。

同时本报告还提供当前全球市场趋势与推动因素以及整体市场环境的最新分析。市场成长的主要因素有呼吸不全和心臟衰竭的发生率增加，新产品上市数的增加，移植手术的增加等。

目录

第1章 摘要整理

• 市场概要

第2章 市场形势

• 市场生态系统

第3章 市场规模

• 市场定义
• 市场区隔分析
• 市场规模 2022
• 市场预测:2022-2027年的预测

第4章 市场规模实际成果

• 全球ECMO(体外式薄膜型人工肺)市场2017～2021年
• 模式市场区隔分析2017-2021
• 产品市场区隔分析2017-2021
• 地区市场区隔分析2017-2021
• 国家市场区隔分析2017-2021

第5章 波特的五力分析

• 五力的摘要
• 买方议价能力
• 供给企业谈判力
• 新加入厂商业者的威胁
• 替代品的威胁
• 竞争的威胁
• 市场情况

第6章 各种模式市场区隔

• 市场·市场区隔
• 各种模式比较
• 从静脉到静脉，从动脉到静脉 - 市场规模与预测 2022-2027
• 从静脉到动脉 - 市场规模与预测 2022-2027
• 各种模式的市场机会

第7章 各产品的市场区隔

• 市场·市场区隔
• 各产品比较
• ECMO设备 - 市场规模与预测 2022-2027
• 软体 - 市场规模与预测 2022-2027
• 各产品的市场机会

第8章 客户形势

• 客户形势概要

第9章 各地区形势

• 各地区市场区隔
• 各地区比较
• 北美 - 市场规模与预测 2022-2027
• 欧洲 - 市场规模与预测 2022-2027
• 亚洲 - 市场规模与预测 2022-2027
• 其他地区(ROW) - 市场规模与预测 2022-2027
• 美国 - 市场规模与预测 2022-2027
• 德国 - 市场规模与预测 2022-2027
• 加拿大 - 市场规模与预测 2022-2027
• 英国 - 市场规模与预测 2022-2027
• 中国 - 市场规模与预测 2022-2027
• 各地区形势的市场机会

第10章 促进因素，课题，及趋势

• 推动市场要素
• 市场课题
• 推动因素与课题的影响
• 市场趋势

第11章 业者情势

• 概要
• 业者情势
• 混乱状况
• 产业的风险

第12章 供应商分析

• 交易厂商
• 供应商的市场定位
• Abbott Laboratories
• Braile Biomedica
• Chalice Medical Ltd.
• Eurosets Srl
• Fresenius Medical Care AG and Co. KGaA
• Getinge AB
• LivaNova Plc
• MC3 Cardiopulmonary
• Medtronic Plc
• MicroPort Scientific Corp.
• Nipro Corp.
• OriGen Biomedical Inc.
• Sechrist Industries Inc.
• Terumo Corp.
• Xenios AG

第13章 附录

Technavio has been monitoring the extracorporeal membrane oxygenation machines market and is forecast to grow by $243.6 million during 2022-2027, accelerating at a CAGR of 10.05% during the forecast period. Our report on the extracorporeal membrane oxygenation machines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of respiratory and heart failure, the rising number of new product launches, and the growing number of transplant procedures.

Technavio's extracorporeal membrane oxygenation machines market is segmented as below:

By Modality

• Veno-venous
• Arterio-venous
• Veno-arterial

By Product

• ECMO machines
• Softwares

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies technological advances as one of the prime reasons driving the extracorporeal membrane oxygenation machines market growth during the next few years. Also, positive results in respiratory failure diseases and treatment in infants will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the extracorporeal membrane oxygenation machines market covers the following areas:

• Extracorporeal membrane oxygenation machines market sizing
• Extracorporeal membrane oxygenation machines market forecast
• Extracorporeal membrane oxygenation machines market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading extracorporeal membrane oxygenation machines market vendors that include Abbott Laboratories, Abiomed Inc., Braile Biomedica, Chalice Medical Ltd., CytoSorbents Europe GmbH, Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Palex Medical SA, Sechrist Industries Inc., Senko Medical Industry Co. Ltd., Spectrum Medical Ltd., Terumo Corp., and Xenios AG. Also, the extracorporeal membrane oxygenation machines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Modality
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global extracorporeal membrane oxygenation machines market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global extracorporeal membrane oxygenation machines market 2017 - 2021 ($ million)
• 4.2 Modality Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Modality Segment 2017 - 2021 ($ million)
• 4.3 Product Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Modality

• 6.1 Market segments
• Exhibit 30: Chart on Modality - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Modality - Market share 2022-2027 (%)
• 6.2 Comparison by Modality
• Exhibit 32: Chart on Comparison by Modality
• Exhibit 33: Data Table on Comparison by Modality
• 6.3 Veno-venous and arterio-venous - Market size and forecast 2022-2027
• Exhibit 34: Chart on Veno-venous and arterio-venous - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Veno-venous and arterio-venous - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Veno-venous and arterio-venous - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Veno-venous and arterio-venous - Year-over-year growth 2022-2027 (%)
• 6.4 Veno-arterial - Market size and forecast 2022-2027
• Exhibit 38: Chart on Veno-arterial - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Veno-arterial - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Veno-arterial - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Veno-arterial - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by Modality
• Exhibit 42: Market opportunity by Modality ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 43: Chart on Product - Market share 2022-2027 (%)
• Exhibit 44: Data Table on Product - Market share 2022-2027 (%)
• 7.2 Comparison by Product
• Exhibit 45: Chart on Comparison by Product
• Exhibit 46: Data Table on Comparison by Product
• 7.3 ECMO machines - Market size and forecast 2022-2027
• Exhibit 47: Chart on ECMO machines - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Data Table on ECMO machines - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Chart on ECMO machines - Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on ECMO machines - Year-over-year growth 2022-2027 (%)
• 7.4 Softwares - Market size and forecast 2022-2027
• Exhibit 51: Chart on Softwares - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on Softwares - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on Softwares - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Softwares - Year-over-year growth 2022-2027 (%)
• 7.5 Market opportunity by Product
• Exhibit 55: Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 59: Chart on Geographic comparison
• Exhibit 60: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.9 Canada - Market size and forecast 2022-2027
• Exhibit 85: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.10 UK - Market size and forecast 2022-2027
• Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.11 China - Market size and forecast 2022-2027
• Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 97: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 98: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 100: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 101: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 102: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 103: Matrix on vendor position and classification
• 12.3 Abbott Laboratories
• Exhibit 104: Abbott Laboratories - Overview
• Exhibit 105: Abbott Laboratories - Business segments
• Exhibit 106: Abbott Laboratories - Key news
• Exhibit 107: Abbott Laboratories - Key offerings
• Exhibit 108: Abbott Laboratories - Segment focus
• 12.4 Braile Biomedica
• Exhibit 109: Braile Biomedica - Overview
• Exhibit 110: Braile Biomedica - Product / Service
• Exhibit 111: Braile Biomedica - Key offerings
• 12.5 Chalice Medical Ltd.
• Exhibit 112: Chalice Medical Ltd. - Overview
• Exhibit 113: Chalice Medical Ltd. - Product / Service
• Exhibit 114: Chalice Medical Ltd. - Key offerings
• 12.6 Eurosets Srl
• Exhibit 115: Eurosets Srl - Overview
• Exhibit 116: Eurosets Srl - Product / Service
• Exhibit 117: Eurosets Srl - Key offerings
• 12.7 Fresenius Medical Care AG and Co. KGaA
• Exhibit 118: Fresenius Medical Care AG and Co. KGaA - Overview
• Exhibit 119: Fresenius Medical Care AG and Co. KGaA - Business segments
• Exhibit 120: Fresenius Medical Care AG and Co. KGaA - Key news
• Exhibit 121: Fresenius Medical Care AG and Co. KGaA - Key offerings
• Exhibit 122: Fresenius Medical Care AG and Co. KGaA - Segment focus
• 12.8 Getinge AB
• Exhibit 123: Getinge AB - Overview
• Exhibit 124: Getinge AB - Business segments
• Exhibit 125: Getinge AB - Key news
• Exhibit 126: Getinge AB - Key offerings
• Exhibit 127: Getinge AB - Segment focus
• 12.9 LivaNova Plc
• Exhibit 128: LivaNova Plc - Overview
• Exhibit 129: LivaNova Plc - Business segments
• Exhibit 130: LivaNova Plc - Key offerings
• Exhibit 131: LivaNova Plc - Segment focus
• 12.10 MC3 Cardiopulmonary
• Exhibit 132: MC3 Cardiopulmonary - Overview
• Exhibit 133: MC3 Cardiopulmonary - Product / Service
• Exhibit 134: MC3 Cardiopulmonary - Key offerings
• 12.11 Medtronic Plc
• Exhibit 135: Medtronic Plc - Overview
• Exhibit 136: Medtronic Plc - Business segments
• Exhibit 137: Medtronic Plc - Key news
• Exhibit 138: Medtronic Plc - Key offerings
• Exhibit 139: Medtronic Plc - Segment focus
• 12.12 MicroPort Scientific Corp.
• Exhibit 140: MicroPort Scientific Corp. - Overview
• Exhibit 141: MicroPort Scientific Corp. - Business segments
• Exhibit 142: MicroPort Scientific Corp. - Key offerings
• Exhibit 143: MicroPort Scientific Corp. - Segment focus
• 12.13 Nipro Corp.
• Exhibit 144: Nipro Corp. - Overview
• Exhibit 145: Nipro Corp. - Business segments
• Exhibit 146: Nipro Corp. - Key offerings
• Exhibit 147: Nipro Corp. - Segment focus
• 12.14 OriGen Biomedical Inc.
• Exhibit 148: OriGen Biomedical Inc. - Overview
• Exhibit 149: OriGen Biomedical Inc. - Product / Service
• Exhibit 150: OriGen Biomedical Inc. - Key offerings
• 12.15 Sechrist Industries Inc.
• Exhibit 151: Sechrist Industries Inc. - Overview
• Exhibit 152: Sechrist Industries Inc. - Product / Service
• Exhibit 153: Sechrist Industries Inc. - Key offerings
• 12.16 Terumo Corp.
• Exhibit 154: Terumo Corp. - Overview
• Exhibit 155: Terumo Corp. - Business segments
• Exhibit 156: Terumo Corp. - Key news
• Exhibit 157: Terumo Corp. - Key offerings
• Exhibit 158: Terumo Corp. - Segment focus
• 12.17 Xenios AG
• Exhibit 159: Xenios AG - Overview
• Exhibit 160: Xenios AG - Product / Service
• Exhibit 161: Xenios AG - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 162: Inclusions checklist
• Exhibit 163: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 164: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 165: Research methodology
• Exhibit 166: Validation techniques employed for market sizing
• Exhibit 167: Information sources
• 13.5 List of abbreviations
• Exhibit 168: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Modality
• Exhibits6: Executive Summary - Chart on Market Segmentation by Product
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global extracorporeal membrane oxygenation machines market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Modality Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Modality - Market share 2022-2027 (%)
• Exhibits31: Data Table on Modality - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Modality
• Exhibits33: Data Table on Comparison by Modality
• Exhibits34: Chart on Veno-venous and arterio-venous - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Veno-venous and arterio-venous - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Veno-venous and arterio-venous - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Veno-venous and arterio-venous - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Veno-arterial - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Veno-arterial - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Veno-arterial - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Veno-arterial - Year-over-year growth 2022-2027 (%)
• Exhibits42: Market opportunity by Modality ($ million)
• Exhibits43: Chart on Product - Market share 2022-2027 (%)
• Exhibits44: Data Table on Product - Market share 2022-2027 (%)
• Exhibits45: Chart on Comparison by Product
• Exhibits46: Data Table on Comparison by Product
• Exhibits47: Chart on ECMO machines - Market size and forecast 2022-2027 ($ million)
• Exhibits48: Data Table on ECMO machines - Market size and forecast 2022-2027 ($ million)
• Exhibits49: Chart on ECMO machines - Year-over-year growth 2022-2027 (%)
• Exhibits50: Data Table on ECMO machines - Year-over-year growth 2022-2027 (%)
• Exhibits51: Chart on Softwares - Market size and forecast 2022-2027 ($ million)
• Exhibits52: Data Table on Softwares - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Chart on Softwares - Year-over-year growth 2022-2027 (%)
• Exhibits54: Data Table on Softwares - Year-over-year growth 2022-2027 (%)
• Exhibits55: Market opportunity by Product ($ million)
• Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits59: Chart on Geographic comparison
• Exhibits60: Data Table on Geographic comparison
• Exhibits61: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits63: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits64: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits67: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits71: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits77: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits78: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits79: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits80: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits83: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits85: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits86: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits87: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits88: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits89: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits91: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits92: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits93: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits94: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits95: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits96: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits97: Market opportunity By Geographical Landscape ($ million)
• Exhibits98: Impact of drivers and challenges in 2022 and 2027
• Exhibits99: Overview on Criticality of inputs and Factors of differentiation
• Exhibits100: Overview on factors of disruption
• Exhibits101: Impact of key risks on business
• Exhibits102: Vendors covered
• Exhibits103: Matrix on vendor position and classification
• Exhibits104: Abbott Laboratories - Overview
• Exhibits105: Abbott Laboratories - Business segments
• Exhibits106: Abbott Laboratories - Key news
• Exhibits107: Abbott Laboratories - Key offerings
• Exhibits108: Abbott Laboratories - Segment focus
• Exhibits109: Braile Biomedica - Overview
• Exhibits110: Braile Biomedica - Product / Service
• Exhibits111: Braile Biomedica - Key offerings
• Exhibits112: Chalice Medical Ltd. - Overview
• Exhibits113: Chalice Medical Ltd. - Product / Service
• Exhibits114: Chalice Medical Ltd. - Key offerings
• Exhibits115: Eurosets Srl - Overview
• Exhibits116: Eurosets Srl - Product / Service
• Exhibits117: Eurosets Srl - Key offerings
• Exhibits118: Fresenius Medical Care AG and Co. KGaA - Overview
• Exhibits119: Fresenius Medical Care AG and Co. KGaA - Business segments
• Exhibits120: Fresenius Medical Care AG and Co. KGaA - Key news
• Exhibits121: Fresenius Medical Care AG and Co. KGaA - Key offerings
• Exhibits122: Fresenius Medical Care AG and Co. KGaA - Segment focus
• Exhibits123: Getinge AB - Overview
• Exhibits124: Getinge AB - Business segments
• Exhibits125: Getinge AB - Key news
• Exhibits126: Getinge AB - Key offerings
• Exhibits127: Getinge AB - Segment focus
• Exhibits128: LivaNova Plc - Overview
• Exhibits129: LivaNova Plc - Business segments
• Exhibits130: LivaNova Plc - Key offerings
• Exhibits131: LivaNova Plc - Segment focus
• Exhibits132: MC3 Cardiopulmonary - Overview
• Exhibits133: MC3 Cardiopulmonary - Product / Service
• Exhibits134: MC3 Cardiopulmonary - Key offerings
• Exhibits135: Medtronic Plc - Overview
• Exhibits136: Medtronic Plc - Business segments
• Exhibits137: Medtronic Plc - Key news
• Exhibits138: Medtronic Plc - Key offerings
• Exhibits139: Medtronic Plc - Segment focus
• Exhibits140: MicroPort Scientific Corp. - Overview
• Exhibits141: MicroPort Scientific Corp. - Business segments
• Exhibits142: MicroPort Scientific Corp. - Key offerings
• Exhibits143: MicroPort Scientific Corp. - Segment focus
• Exhibits144: Nipro Corp. - Overview
• Exhibits145: Nipro Corp. - Business segments
• Exhibits146: Nipro Corp. - Key offerings
• Exhibits147: Nipro Corp. - Segment focus
• Exhibits148: OriGen Biomedical Inc. - Overview
• Exhibits149: OriGen Biomedical Inc. - Product / Service
• Exhibits150: OriGen Biomedical Inc. - Key offerings
• Exhibits151: Sechrist Industries Inc. - Overview
• Exhibits152: Sechrist Industries Inc. - Product / Service
• Exhibits153: Sechrist Industries Inc. - Key offerings
• Exhibits154: Terumo Corp. - Overview
• Exhibits155: Terumo Corp. - Business segments
• Exhibits156: Terumo Corp. - Key news
• Exhibits157: Terumo Corp. - Key offerings
• Exhibits158: Terumo Corp. - Segment focus
• Exhibits159: Xenios AG - Overview
• Exhibits160: Xenios AG - Product / Service
• Exhibits161: Xenios AG - Key offerings
• Exhibits162: Inclusions checklist
• Exhibits163: Exclusions checklist
• Exhibits164: Currency conversion rates for US$
• Exhibits165: Research methodology
• Exhibits166: Validation techniques employed for market sizing
• Exhibits167: Information sources
• Exhibits168: List of abbreviations